Source: ERJ Open Res, 7 (3) 00617-2020; 10.1183/23120541.00617-2020
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Laurence Halimi, Carey M. Suehs, Gregory Marin, Clement Boissin, Anne-Sophie Gamez, Isabelle Vachier, Nicolas Molinari, Arnaud Bourdin. Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study. ERJ Open Res, 7 (3) 00617-2020; 10.1183/23120541.00617-2020

Member's Comments

No comment yet.

Related content which might interest you: Health-related quality of life in patients with pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Pulmonary arterial hypertension: the burden of disease and impact on quality of life Source: Eur Respir Rev 2015; 24: 621-629 Year: 2015 Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Health-related quality of life in patients with chronic obstructive pulmonary disease: effects of hospital-based home-care programme Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease Year: 2009 Predictors of health-related quality of life in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 66s Year: 2006 emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension Source: Eur Respir J 2014; 43: 1106-1113 Year: 2014 The assessment of life expectancy of patients with primary pulmonary hypertension (PPH) Source: Eur Respir J 2003; 22: Suppl. 45, 582s Year: 2003 Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Dyspnoa and health-related quality of life in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 570s Year: 2006 EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study Source: Eur Respir J, 57 (2) 2000124; 10.1183/13993003.00124-2020 Year: 2021 EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multi-centre study Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension Year: 2020 Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Impact of macitentan on the health-related quality of life (HRQoL) in pulmonary arterial hypertension (PAH): Results from a long-term randomised controlled trial Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Sildenafil improves health-related quality of life in pulmonary arterial hypertension (PAH) patients Source: Eur Respir J 2005; 26: Suppl. 49, 563s Year: 2005 Effects of tadalafil on health-related quality of life in patients with pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009 Health-related quality of life and health status among patients with sarcoidosis, chronic obstructive pulmonary disease and interstitial lung disease Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Health-related quality of life in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 The effect of pulmonary rehabilitation on health-related quality of life in patients with pulmonary sarcoidosis Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018 EmPHasis-10 is associated with clinical outcome measures in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013